Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Falcão

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Arquivos Brasileiros De Cardiologia|August 10, 2000
Lupus carditisC A Falcão, N Lucena, I C Alves, et al.
Biochemical and Biophysical Research Communications|March 5, 2017
Validation of Mycobacterium tuberculosis dihydroneopterin aldolase as a molecular target for anti-tuberculosis drug developmentV C A Falcão, A D Villela, V S Rodrigues-Junior, et al.
Tuberculosis (Edinburgh, Scotland)|March 22, 2018
Effect of the bradykinin 1 receptor antagonist SSR240612 after oral administration in Mycobacterium tuberculosis-infected miceValnês S Rodrigues-Junior, Priscilla B Pail, Anne D Villela, et al.
Stem Cell Reports|November 5, 2019
Drug Discovery Platform Targeting M. tuberculosis with Human Embryonic Stem Cell-Derived MacrophagesHyo-Won Han, Hyang-Hee Seo, Hye-Yeong Jo, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Arquivos Brasileiros De Cardiologia|August 10, 2000
Lupus carditisC A Falcão, N Lucena, I C Alves, et al.
Biochemical and Biophysical Research Communications|March 5, 2017
Validation of Mycobacterium tuberculosis dihydroneopterin aldolase as a molecular target for anti-tuberculosis drug developmentV C A Falcão, A D Villela, V S Rodrigues-Junior, et al.
Tuberculosis (Edinburgh, Scotland)|March 22, 2018
Effect of the bradykinin 1 receptor antagonist SSR240612 after oral administration in Mycobacterium tuberculosis-infected miceValnês S Rodrigues-Junior, Priscilla B Pail, Anne D Villela, et al.
Stem Cell Reports|November 5, 2019
Drug Discovery Platform Targeting M. tuberculosis with Human Embryonic Stem Cell-Derived MacrophagesHyo-Won Han, Hyang-Hee Seo, Hye-Yeong Jo, et al.
Pageof 1